• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉输注期间猪体内非莫西汀的肝脏消除情况。

Hepatic elimination of femoxetine in pig during intravenous infusion.

作者信息

Keiding S, Mengel H, Lund J

出版信息

Acta Pharmacol Toxicol (Copenh). 1983 Mar;52(3):234-7. doi: 10.1111/j.1600-0773.1983.tb01092.x.

DOI:10.1111/j.1600-0773.1983.tb01092.x
PMID:6846032
Abstract

Hepatic elimination of femoxetine was studied in six anaesthetized pigs during intravenous administration. Femoxetine was given into a jugular vein as a constant infusion of 0.4-7.2 mg/min. in five pigs and as a bolus injection of 383 mg in one pig. The hepatic extraction was high (92-98%) corresponding to earlier findings of 91-99% when femoxetine was infused into the portal vein in pig or given orally to man. The urinary excretion was low, less than 5% of the dose, and the estimated extrahepatic metabolism was not significantly different from zero.

摘要

在六只麻醉猪静脉给药期间研究了非莫西汀的肝脏消除情况。五只猪以0.4 - 7.2毫克/分钟的恒定速率通过颈静脉输注非莫西汀,一只猪静脉推注383毫克。肝脏提取率很高(92 - 98%),这与之前的研究结果相符,即在猪中通过门静脉输注非莫西汀或给人口服时,提取率为91 - 99%。尿排泄量很低,不到给药剂量的5%,并且估计的肝外代谢与零无显著差异。

相似文献

1
Hepatic elimination of femoxetine in pig during intravenous infusion.静脉输注期间猪体内非莫西汀的肝脏消除情况。
Acta Pharmacol Toxicol (Copenh). 1983 Mar;52(3):234-7. doi: 10.1111/j.1600-0773.1983.tb01092.x.
2
Hepatic elimination of femoxetine in pig.猪体内非莫西汀的肝脏消除
Acta Pharmacol Toxicol (Copenh). 1983 Jan;52(1):1-7. doi: 10.1111/j.1600-0773.1983.tb01067.x.
3
Femoxetine clearance in patients with liver cirrhosis.肝硬化患者中氟西汀的清除率。
Acta Pharmacol Toxicol (Copenh). 1984 Nov;55(5):386-90. doi: 10.1111/j.1600-0773.1984.tb01999.x.
4
Femoxetine and cimetidine: interaction in healthy volunteers.
Eur J Clin Pharmacol. 1986;31(3):299-302. doi: 10.1007/BF00981127.
5
Pharmacokinetics of femoxetine in man.非莫西汀在人体中的药代动力学。
Acta Pharmacol Toxicol (Copenh). 1979 Mar;44(3):177-84. doi: 10.1111/j.1600-0773.1979.tb02314.x.
6
Hepatic galactose elimination kinetics in the intact pig.完整猪肝脏中半乳糖清除动力学
Scand J Clin Lab Invest. 1982 May;42(3):253-9.
7
Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.口服、外周静脉注射和门静脉注射葡萄糖对清醒犬肝脏葡萄糖摄取以及胰岛素和胰高血糖素提取的不同影响。
J Clin Invest. 1983 Aug;72(2):590-601. doi: 10.1172/JCI111007.
8
Inactivation of 5-fluorouracil by the liver during continuous regional and systemic infusion in pigs.猪在持续区域和全身输注过程中肝脏对5-氟尿嘧啶的灭活作用。
Eur Surg Res. 1976;8(6):489-96. doi: 10.1159/000127895.
9
Femoxetine in asthma.非莫西汀与哮喘
Allergy. 1983 May;38(4):283-5. doi: 10.1111/j.1398-9995.1983.tb01621.x.
10
Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs.阿托品和胃抑制性多肽对清醒犬肝脏葡萄糖摄取及胰岛素提取的影响。
J Clin Invest. 1985 Sep;76(3):1174-81. doi: 10.1172/JCI112073.

引用本文的文献

1
A nonlinear physiologic pharmacokinetic model: I. Steady-state.一种非线性生理药代动力学模型:I. 稳态
J Pharmacokinet Biopharm. 1985 Feb;13(1):73-92. doi: 10.1007/BF01073657.